Cargando…
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
BACKGROUND: Paclitaxel induced peripheral neuropathy (PIPN) is a major debilitating side effect of paclitaxel in patients with breast cancer with no fully known mechanisms. The aim of the study was to find out the possible risk factors for PIPN. METHODS: Eligible patients with node positive breast c...
Autores principales: | Ghoreishi, Zohreh, Keshavarz, Seyedali, Asghari Jafarabadi, Mohammad, Fathifar, Zahra, Goodman, Karyn A, Esfahani, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173931/ https://www.ncbi.nlm.nih.gov/pubmed/30290775 http://dx.doi.org/10.1186/s12885-018-4869-5 |
Ejemplares similares
-
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
por: Ghoreishi, Zohreh, et al.
Publicado: (2012) -
The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial
por: Esfahani, Ali, et al.
Publicado: (2016) -
Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer
por: Esfahani, Ali, et al.
Publicado: (2016) -
The effect of zingiber officinale on prooxidant-antioxidant balance and glycemic control in diabetic patients with ESRD undergoing hemodialysis: a double-blind randomized control trial
por: Rostamkhani, Helya, et al.
Publicado: (2023) -
Effect of Zingiber officinale on Lipid Profile and Some Inflammatory Markers in Diabetic Hemodialysis Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial
por: Veisi, Parisa, et al.
Publicado: (2023)